Low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small-cell lung cancer: a phase I and II trials

被引：0
|
作者：
Zwitter, M [1 ]
Kovac, V [1 ]
Smrdel, U [1 ]
Kocijancic, I [1 ]
机构：
[1] Inst Oncol, Ljubljana, Slovenia
来源：
LUNG CANCER | 2004年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S77 / S78
页数：2
相关论文
共 50 条
  • [1] Phase II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer
    Xiong, Jian Ping
    Feng, Miao
    Qiu, Feng
    Xu, Jun
    Tao, Qing Song
    Zhang, Ling
    Xiang, Xiao Jun
    Zhong, Lu Xing
    Yu, Feng
    Ma, Xu Tian
    Gong, Wang Yong
    [J]. LUNG CANCER, 2008, 60 (02) : 208 - 214
  • [2] Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer
    Zwitter, M
    Kovac, V
    Smrdel, U
    Kocijancic, I
    Segedin, B
    Vrankar, M
    [J]. ANTI-CANCER DRUGS, 2005, 16 (10) : 1129 - 1134
  • [3] Low-dose gemcitabine in prolonged infusion and cisplatin for malignant pleural mesothelioma: a phase I and II trials
    Kovac, V
    Zwitter, M
    Smrdel, U
    Debeljak, A
    Cesar, R
    Izidor, K
    [J]. LUNG CANCER, 2004, 45 : S68 - S68
  • [4] Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer A Randomized Phase II Clinical Trial
    Zwitter, Matjaz
    Kovac, Viljem
    Smrdel, Uros
    Vrankar, Martina
    Zadnik, Vesna
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : 1148 - 1155
  • [5] Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer
    J. Feliu
    G. Martín
    C. Madroñal
    A. Rodríguez-Jaráiz
    J. Castro
    A Rodríguez
    T. Checa
    M. Bolaño
    E. Casado
    M. González-Barón
    [J]. Cancer Chemotherapy and Pharmacology, 2003, 52 : 247 - 252
  • [6] Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer
    Feliu, J
    Martín, G
    Madroñal, C
    Rodríguez-Jaráiz, A
    Castro, J
    Rodríguez, A
    Checa, T
    Bolaño, M
    Casado, E
    González-Barón, M
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (03) : 247 - 252
  • [7] GEMCITABINE IN BRIEF STANDARD DOSE VERSUS PROLONGED LOW-DOSE INFUSION, BOTH COMBINED WITH CISPLATIN FOR ADVANCED NON-SMALL CELL LUNG CANCER
    Beniwal, S. K.
    Jakhar, S. L.
    Bagri, P. K.
    Sharma, N.
    Kumar, H.
    Sharma, A.
    Singhal, M.
    Singh, D.
    Singh, G.
    Kapoor, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S46 - S46
  • [8] Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II study
    Lippe, P
    Tummarello, D
    Monterubbianesi, MC
    Silva, RR
    Giuliodori, L
    Mari, D
    Santo, A
    Pasini, E
    Cetto, GL
    Rossi, D
    Porfiri, E
    Cascinu, S
    Cellerino, R
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (02) : 217 - 221
  • [9] A phase II trial of low dose prolonged infusion gemcitabine and cisplatin in advanced bladder cancer
    Khaled, Hussein M.
    El-Khodary, Ahmed I.
    Emara, Mohamed E.
    Gaafar, Rabab M.
    Mansour, Osman
    Warith, Amed Abdei
    Zaghloul, Mohamed S.
    El Malt, Osama
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 118 - 118
  • [10] Phase II Trial of Weekly Gemcitabine and Split-dose Cisplatin for Advanced Non-small-cell Lung Cancer
    Hiramatsu, Atsushi
    Iwasaki, Yoshinobu
    Koyama, Yasunori
    Tamiya, Nobuyo
    Hosogi, Shigekuni
    Nakanishi, Masaki
    Kohno, Yoshihito
    Ueda, Mikio
    Arimoto, Taichiro
    Marunaka, Yoshinori
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (12) : 779 - 783
12345